These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 28182203

  • 21. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers.
    Yuan JM, Gao YT, Murphy SE, Carmella SG, Wang R, Zhong Y, Moy KA, Davis AB, Tao L, Chen M, Han S, Nelson HH, Yu MC, Hecht SS.
    Cancer Res; 2011 Nov 01; 71(21):6749-57. PubMed ID: 22028322
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
    Richie JP, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct 01; 6(10):783-90. PubMed ID: 9332760
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers.
    Perez-Paramo YX, Watson CJW, Chen G, Thomas CE, Adams-Haduch J, Wang R, Khor CC, Koh WP, Nelson HH, Yuan JM, Lazarus P.
    Cancer Epidemiol Biomarkers Prev; 2023 Jan 09; 32(1):54-65. PubMed ID: 36252563
    [Abstract] [Full Text] [Related]

  • 26. Association between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies.
    Liu T, Xie CB, Ma WJ, Chen WQ.
    Environ Mol Mutagen; 2013 Mar 09; 54(2):133-40. PubMed ID: 23203414
    [Abstract] [Full Text] [Related]

  • 27. Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.
    Ezzeldin N, El-Lebedy D, Darwish A, El Bastawisy A, Abd Elaziz SH, Hassan MM, Saad-Hussein A.
    BMC Cancer; 2018 May 03; 18(1):525. PubMed ID: 29724170
    [Abstract] [Full Text] [Related]

  • 28. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG, Borukhova A, Akerkar SA, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 1997 Feb 03; 6(2):113-20. PubMed ID: 9037562
    [Abstract] [Full Text] [Related]

  • 29. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations.
    Wassenaar CA, Ye Y, Cai Q, Aldrich MC, Knight J, Spitz MR, Wu X, Blot WJ, Tyndale RF.
    Carcinogenesis; 2015 Jan 03; 36(1):99-103. PubMed ID: 25416559
    [Abstract] [Full Text] [Related]

  • 30. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
    Ariyoshi N, Miyamoto M, Umetsu Y, Kunitoh H, Dosaka-Akita H, Sawamura Y, Yokota J, Nemoto N, Sato K, Kamataki T.
    Cancer Epidemiol Biomarkers Prev; 2002 Sep 03; 11(9):890-4. PubMed ID: 12223434
    [Abstract] [Full Text] [Related]

  • 31. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.
    Church TR, Anderson KE, Caporaso NE, Geisser MS, Le CT, Zhang Y, Benoit AR, Carmella SG, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 03; 18(1):260-6. PubMed ID: 19124507
    [Abstract] [Full Text] [Related]

  • 32. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex.
    Zhu AZ, Renner CC, Hatsukami DK, Swan GE, Lerman C, Benowitz NL, Tyndale RF.
    Cancer Epidemiol Biomarkers Prev; 2013 Apr 03; 22(4):708-18. PubMed ID: 23371292
    [Abstract] [Full Text] [Related]

  • 33. Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers.
    Stepanov I, Upadhyaya P, Carmella SG, Feuer R, Jensen J, Hatsukami DK, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 2008 Jul 03; 17(7):1764-73. PubMed ID: 18628430
    [Abstract] [Full Text] [Related]

  • 34. Genetic variants in CYP2A6 and UGT1A9 genes associated with urinary nicotine metabolites in young Mexican smokers.
    Borrego-Soto G, Perez-Paramo YX, Chen G, Santuario-Facio SK, Santos-Guzman J, Posadas-Valay R, Alvarado-Monroy FM, Balderas-Renteria I, Medina-Gonzalez R, Ortiz-Lopez R, Lazarus P, Rojas-Martinez A.
    Pharmacogenomics J; 2020 Aug 03; 20(4):586-594. PubMed ID: 31959879
    [Abstract] [Full Text] [Related]

  • 35. A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure.
    Shepperd CJ, Eldridge AC, Mariner DC, McEwan M, Errington G, Dixon M.
    Regul Toxicol Pharmacol; 2009 Oct 03; 55(1):97-109. PubMed ID: 19539004
    [Abstract] [Full Text] [Related]

  • 36. Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers.
    Tulunay OE, Hecht SS, Carmella SG, Zhang Y, Lemmonds C, Murphy S, Hatsukami DK.
    Cancer Epidemiol Biomarkers Prev; 2005 May 03; 14(5):1283-6. PubMed ID: 15894687
    [Abstract] [Full Text] [Related]

  • 37. Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.
    Yuan JM, Knezevich AD, Wang R, Gao YT, Hecht SS, Stepanov I.
    Carcinogenesis; 2011 Sep 03; 32(9):1366-71. PubMed ID: 21734256
    [Abstract] [Full Text] [Related]

  • 38. The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
    Brown B, Avalos J, Lee C, Doolittle D.
    Mutat Res; 2001 Jul 25; 494(1-2):21-9. PubMed ID: 11423342
    [Abstract] [Full Text] [Related]

  • 39. Chinese 'low-tar' cigarettes do not deliver lower levels of nicotine and carcinogens.
    Gan Q, Lu W, Xu J, Li X, Goniewicz M, Benowitz NL, Glantz SA.
    Tob Control; 2010 Oct 25; 19(5):374-9. PubMed ID: 20507920
    [Abstract] [Full Text] [Related]

  • 40. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes.
    Hecht SS, Murphy SE, Carmella SG, Li S, Jensen J, Le C, Joseph AM, Hatsukami DK.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 25; 14(3):693-8. PubMed ID: 15767351
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.